Introduction
Reconstituting tissues and organs is among the biggest dreams of scientists for a long time, especially in the field of clinical medicine and recently regenerative medicine. Those tissues and organs reconstituted could potentially be used for implantation without any immunological rejection, and also for testing medicinal properties of drugs. Despite these promising prospects, it is still so difficult to realize them that only a few examples, ex. skins, are to be in practical use. The difficulty mostly comes from the complicated structures and functionalities of the tissues closely related to their developments into three-dimensional shapes. Microfluidics is one of the emerging technologies that is helpful for achieving important features for tissue engineering applications, i.e. 'predetermined' microscopic structures and 'controlled' fluidic functions. In its definition, a microfluidic device should contain microstructures, often noted as 'microchannels' or 'microfluidic networks'. These structures could work as three-dimensional supports for the cultured cells in the device. And they could, of course, function as fluidic conduits to enhance the circulation of the substances, which have to be supplied or removed to maintain comfortable conditions for the cells inside. In this talk, fundamental techniques to fabricated microfluidic devices and to culture cells are presented and some of the results from our experimental attempts towards in vitro liver tissue reconstitution will be shown for further discussion on the future development
PDMS Microfuidic Devices
PDMS (polydimethylsiloxane) is a widely used material in the field of microfluidics [1, 2] including cell culture applications [3, 4] . One of the remarkable advantages of this material is suitability for microfabrication through replica molding process even with three-dimensional structures. PDMS is known as one of the biocompatible materials and has high gas permeability, which is again suitable for cell culture applications in terms of oxygen supply. Moreover, optical property of PDMS is convenient both for direct and fluorescence-based observation of the morphology and biological activities of cultured cells under a microscope. We've been also using PDMS as a material for the microfluidic cell-culture devices. In order to achieve the growth of the cultured cells in three-dimensional spaces, microfluidic devices with multi-step structures, as shown in Fig.1 , are introduced. The devices are mostly fabricated through the standard replica molding process except the fact that the mold masters contain multi-step negative structures for the microfluidic channels.
The fabrication process of the multi-step microfluidic channels is shown in Fig.2 . After the standard cleaning of a silicon wafer, SU-8 50 (Microchem, USA) is spin-coated on a glass substrate. The SU-8 layer is exposed to UV light for several seconds and baked. An additional layer of SU-8 is spin-coated and patterned before the post-baking. These steps are repeated according to the number of layers to be stacked. After all the repeating steps, post-bake is done followed by development and rinse steps. The fabricated mold master with the multi-step microstructure will be treated by CHF 3 plasma for easy release of the PDMS layer. PDMS prepolymer mixed with curing reagent is poured onto the mold master and is cured by heating in an oven. The PDMS layer is peeled off from the master, and then access holes are drilled as an inlet and an outlet to/from the microfluidic channels. To form a complete microfluidic device, two PDMS layers are permanently bonded together by applying O 2 plasma again. This plasma treatment also makes the walls of the microchannels hydrophilic, which is favorable to introduction of the culture media into the device. The complete device is connected into the external fluidic system via silicone tubes. Figure 3 illustrates the typical perfusion circuit used in our experiments. It consists of a culture medium tank, a peristaltic pump, and a glass-made bubble trap. The minimum flow rate with this system is 5 µl/min. Figure 4 shows the typical situation of Hep G2 cells cultured in the microfluidic device. In several days, cells stably attached onto the structure, and grow into aggregated forms. And it could reach at confluence in approximately one week (Fig.4B) . By measuring glucose consumption and albumin production of the cultured cells, tt was confirmed that the cells could be kept in good condition maintaining its physiological functions for up to two weeks, as long as the culture medium is properly refreshed. Usually we start the culture by inoculating 1 x 10 5 cells per device, which is approximately 4 x 10 4 cells/cm 2 , and growth ratio is around 20 on the 9 th day of the culture 3. Future Persupectives . Although the application of microfluidic devices to cell and tissue engineering has just been initiated, we've already become sure that microfluidic environments could bring remarkable features to the cells in terms of physical and chemical conditions to survive and grow. We can think of various kinds of applications of this technology, for example, temporary support for the hospitalized patients, model tissues for drug screening, environmental toxicity testing, tools for ART (Assisted Reproductive Technologies), implantable tissues reconstructed in vitro, etc. Some of the examples that are currently under development will be addressed in the presentation.
Culture Experiments

